Epinephrine and dDAVP administration in patients with congenital nephrogenic diabetes insipidus
- 1 November 1989
- journal article
- research article
- Published by Elsevier in Kidney International
- Vol. 36 (5), 859-866
- https://doi.org/10.1038/ki.1989.272
Abstract
No abstract availableKeywords
This publication has 30 references indexed in Scilit:
- Hemodynamic and Coagulation Responses to 1-Desamino[8-D-Arginine] Vasopressin in Patients with Congenital Nephrogenic Diabetes InsipidusNew England Journal of Medicine, 1988
- Effects of a specific antidiuretic agonist on cardiac output and its distribution in intact and anephric dogsClinical Science, 1988
- Clinical application of the chromogenic assay of factor VIII in haemophilia A, and different variants of von Willebrand's diseaseScandinavian Journal of Haematology, 1986
- Modulation of plasma and platelet vasopressin by cardiac function in patients with heart failureKidney International, 1986
- ELECTROBLOTTING OF FACTOR VIII/VON WILLEBRAND FACTOR MULTIMERS AFTER ELECTROPHORESIS IN SDS–AGAROSE GEL, DISCONTINUOUS BUFFER SYSTEMBritish Journal of Haematology, 1983
- An electroblotting technique for the detection of factor VIII/von Willebrand factor multimers in plasmaBritish Journal of Haematology, 1983
- A sensitive assay for tissue plasminogen activatorThrombosis Research, 1982
- Multimeric composition of factor VIII/von Willebrand factor following administration of DDAVP: implications for pathophysiology and therapy of von Willebrand's disease subtypesBlood, 1982
- Mechanism of Plasminogen Activator and Factor VIII Increase after Vasoactive DrugsBritish Journal of Haematology, 1975
- Nephrogenic Diabetes Insipidus in North America — TheHopewellHypothesisNew England Journal of Medicine, 1969